Document is current
Any future updates will be listed below
-
Authors
Mellinghoff, Sibylle C. https://orcid.org/0000-0003-3928-2503
Bruns, Caroline
Albertsmeier, Markus https://orcid.org/0000-0002-5028-5062
Ankert, Juliane https://orcid.org/0000-0001-6248-6307
Bernard, Louis https://orcid.org/0000-0001-8127-7519
Budin, Sofia
Bataille, Camille https://orcid.org/0000-0002-0141-4796
Classen, Annika Y. https://orcid.org/0000-0003-2905-5139
Cornely, Florian B.
Couvé-Deacon, Elodie https://orcid.org/0000-0002-5245-531X
Fernandez Ferrer, Maria
Fortún, Jesús https://orcid.org/0000-0002-6959-5263
Galar, Alicia https://orcid.org/0000-0002-9310-8752
Grill, Eva
Guimard, Thomas
Hampl, Jürgen A.
Wingen-Heimann, Sebastian https://orcid.org/0000-0002-4232-6944
Horcajada, Juan P. https://orcid.org/0000-0001-9873-5459
Köhler, Felix
Koll, Carolin
Mollar, Joan
Muñoz, Patricia https://orcid.org/0000-0001-6817-913X
Pletz, Mathias W.
Rutz, Jule
Salmanton-García, Jon
Seifert, Harald
Serracino-Inglott, Ferdinand https://orcid.org/0000-0002-3188-7957
Soriano, Alex
Stemler, Jannik https://orcid.org/0000-0001-9152-2469
Vehreschild, Janne J. https://orcid.org/0000-0002-5446-7170
Vilz, Tim O. https://orcid.org/0000-0002-3763-7158
Naendrup, Jan-Hendrik https://orcid.org/0000-0002-6420-7938
Cornely, Oliver A. https://orcid.org/0000-0001-9599-3137
Liss, Blasius J. https://orcid.org/0000-0002-3551-3450
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 24 April 2023
Accepted: 13 September 2023
First Online: 19 September 2023
Declarations
:
: The study is a retrospective study and was submitted to the Research Ethics Commission of the University of Cologne (No. 17–078) for advice; the requirement for informed consent was waived due to the retrospective nature as well as the anonymous data capture strategy of this study. The study was registered at clinicaltrials.gov under NCT03353532.
: All authors have completed the ICMJE uniform disclosure form at and declare the following: EG reports grants from German Federal Ministry of Education and Research, the EU, and the German Statutory Health Insurances, personal fees from the Bavarian association of statutory health insurance registered doctors, not related to this work. TG reports report personnal fees from Pfizer, Gilead and Viiv healthcare. FK reports grants from Else Kröner-Fresenius-Stiftung, grants from German Research Foundation under Germany's Excellence Strategy—EXC 2030: CECAD—Excellent in Aging Research—Project number 390661388, grants from Koeln Fortune program / Faculty of Medicine, University of Cologne, outside the submitted work. SCM reports grants from University of Cologne (KoelnFortune), grants from Dr Manfred Plempel Stipend, grants from DZIF Clinical Leave, personal fees from Octapharma, outside the submitted work. MWP reports grants for the German Research Foundation, the German Ministry for Education and Research, grants and personal fees from Pfizer, personal fees from MSD, personal fees from Infectopharm, personal fees from Thermofisher, personal fees from Shionogi, personal fees from Angelini, personal fees from Chiemsi, personal fees from Novartis, outside the submitted work. HS reports grants from German Centre for Infection Research (DZIF), personal fees from Basilea Pharmaceuticals, personal fees from Gilead, personal fees from MSD, personal fees from Entasis, grants from Accelerate, personal fees from Shionogi, personal fees from ThermoFisher, personal fees from bioMérieux, personal fees from Becton Dickinson, personal fees from Shionogi, personal fees from Eumedica, outside the submitted work. AS reports grants from PFIZER, grants from MERCK SHARP DHOME, grants from GILEAD, personal fees from MENARINI, personal fees from ANGELINI, personal fees from SHIONOGY, outside the submitted work. JS reports grants from German Federal Ministry of Education and Research, grants from Basilea Pharmaceuticals Inc., grants from German Society for Infectious Diseases, grants from Meta-Alexander Foundation, outside the submitted work. JJV has personal fees from Merck / MSD, Gilead, Pfizer, Astellas Pharma, Basilea, German Centre for Infection Research (DZIF), University Hospital Freiburg/ Congress and Communication, Academy for Infectious Medicine, University Manchester, German Society for Infectious Diseases (DGI), Ärztekammer Nordrhein, University Hospital Aachen, Back Bay Strategies, German Society for Internal Medicine (DGIM), Shionogi, Molecular Health, Netzwerk Universitätsmedizin, Janssen, NordForsk, and grants from Merck / MSD, Gilead, Pfizer, Astellas Pharma, Basilea, German Centre for Infection Research (DZIF), German Federal Ministry of Education and Research (BMBF), (PJ-T: DLR), University of Bristol, Rigshospitalet Copenhagen. OAC reports grants or contracts from Amplyx, Basilea, BMBF, Cidara, DZIF, EU-DG RTD (101037867), F2G, Gilead, Matinas, MedPace, MSD, Mundipharma, Octapharma, Pfizer, Scynexis; Consulting fees from Abbvie, Amplyx, Biocon, Biosys, Cidara, Da Volterra, Gilead, IQVIA, Janssen, Matinas, MedPace, Menarini, Molecular Partners, MSG-ERC, Noxxon, Octapharma, Pardes, Pfizer, PSI, Scynexis, Seres; Honoraria for lectures from Abbott, Abbvie, Al-Jazeera Pharmaceuticals, Astellas, Gilead, Grupo Biotoscana/United Medical/Knight, Hikma, MedScape, MedUpdate, Merck/MSD, Mylan, Noscendo, Pfizer, Shionogi; Payment for expert testimony from Cidara; Participation on a Data Safety Monitoring Board or Advisory Board from Actelion, Allecra, Cidara, Entasis, IQVIA, Janssen, MedPace, Paratek, PSI, Pulmocide, Shionogi, The Prime Meridian Group; A patent at the German Patent and Trade Mark Office (DE 10 2021 113 007.7); Stocks from CoRe Consulting; Other interests from DGHO, DGI, ECMM, ISHAM, MSG-ERC, Wiley., outside the submitted work. BJL reports grants from Pfizer, during the conduct of the study. The remaining authors have nothing to disclose.
